BSE filing, NSE: ARCFIN. Summary written from the filing by ALFA Finder's alert engine.
ARC Finance Ltd: key numbers
- Share price
- ₹0.43
- Market cap
- ₹37.47 Cr
- Revenue (annual)
- ₹28.06 Cr
- Net profit (annual)
- ₹0.72 Cr
- P/E (TTM)
- 49.3×Sector 19.7×
- Promoter holding
- 6.97%+0.00% QoQ
- FII holding
- 0.00%Current quarter
Reference market data from a third-party provider, updated daily. Not a valuation or a recommendation.
More from ARC Finance Ltd
All →ARC Finance Annual General Meeting
ARC Finance Limited conducted its 44th Annual General Meeting on September 30, 2026. Shareholders considered the adoption of audited financial statements and the re-appointment of Director Shikha Singhal.
ARC Finance Annual Report
ARC Finance Limited filed its 44th Annual Report for FY 2025-26. The report includes corporate details and the 44th AGM notice dated 30 September 2026.
ARC Finance Other Announcement
ARC Finance Ltd informed exchanges that its register of members and transfer books close 24–30 September 2026. The closure is for its 44th AGM held 30 September 2026.
ARC Finance Annual General Meeting
ARC Finance Limited has called its 44th Annual General Meeting for 30 September 2026 via video conference. Agenda includes adopting FY26 audited accounts and re-appointing a director.
ARC Finance Board Meeting Outcome
ARC Finance Limited's board approved the FY 2025-26 annual reports and scheduled the 44th Annual General Meeting for September 30, 2026. The book closure is set for September 24-30.
ARC Finance Board Meeting Date
ARC Finance Limited scheduled a board meeting for September 4, 2026. The board will approve the Director's Report and fix the 44th Annual General Meeting details.
Other other announcement announcements
All →Aarti Pharmalabs Other Announcement
Aarti Pharmalabs has intimated under Regulation 46 that it revamped its website at the existing URL to improve design and accessibility. The notice has no financial or business substance.
Sagarsoft (India) Other Announcement
Sagarsoft (India) filed its Regulation 32 fund utilisation statement for its 2021 preferential issue. No deviation was reported and the full Rs.5.08 Crore was used.
Sadhana Nitro Chem Other Announcement
Sadhana Nitro Chem reported no deviation in use of its preferential issue proceeds for the quarter ended September 2026. The Audit Committee reviewed the statement.
Shriram Asset Management Company Other Announcement
Shriram AMC filed ICRA's quarterly monitoring agency report on preferential issue proceeds. Utilisation is in line with the offer objects, with no deviation reported.
Jhandewalas Foods Other Announcement
Jhandewalas Foods filed its quarterly shareholding pattern for the period ended September 30, 2026. The filing records holdings by category and contains no transaction or money event.
Avience Biomedicals Other Announcement
Avience Biomedicals confirmed corporate governance compliance is not applicable, as it is SME-listed on NSE Emerge. No quarterly governance report is required for September 2026.